Search research articles
Contact Us
Filters
Showing results (31-40 of 106) with videos related to
Page
of 11
Sort By:
Plos One
|
April 28, 2010
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
Catarina E Hioe, Terri Wrin, Michael S Seaman, et al.
Journal of Virology
|
November 27, 2004
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10
Saurabh Mehandru, Terri Wrin, Justin Galovich, et al.
Journal of Virology
|
April 29, 2005
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B
Simon D W Frost, Yang Liu, Sergei L Kosakovsky Pond, et al.
Journal of Virology
|
April 29, 2005
Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1
Javier Martinez-Picado, Terri Wrin, Simon D W Frost, et al.
AIDS (London, England)
|
April 16, 2002
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity
Julia G Prado, Terri Wrin, Jeff Beauchaine, et al.
AIDS Research and Human Retroviruses
|
June 14, 2003
Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations
Stephen Taylor, Patricia Cane, Stéphane Hué, et al.
AIDS (London, England)
|
September 26, 2014
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study
Jonathan Z Li, Andrea Heisey, Hayat Ahmed, et al.
AIDS (London, England)
|
October 9, 2002
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates
Jeannette M Whitcomb, Wei Huang, Kay Limoli, et al.
Plos One
|
March 21, 2015
Glycans flanking the hypervariable connecting peptide between the A and B strands of the V1/V2 domain of HIV-1 gp120 confer resistance to antibodies that neutralize CRF01_AE viruses
Sara M O'Rourke, Ruengpung Sutthent, Pham Phung, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
December 13, 2023
SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk
Mazen Khalifeh, Lorry G Rubin, David Dayya, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 106) with videos related to
Sort By:
Page
of 11
Plos One
|
April 28, 2010
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
Catarina E Hioe, Terri Wrin, Michael S Seaman, et al.
Journal of Virology
|
November 27, 2004
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10
Saurabh Mehandru, Terri Wrin, Justin Galovich, et al.
Journal of Virology
|
April 29, 2005
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B
Simon D W Frost, Yang Liu, Sergei L Kosakovsky Pond, et al.
Journal of Virology
|
April 29, 2005
Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1
Javier Martinez-Picado, Terri Wrin, Simon D W Frost, et al.
AIDS (London, England)
|
April 16, 2002
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity
Julia G Prado, Terri Wrin, Jeff Beauchaine, et al.
AIDS Research and Human Retroviruses
|
June 14, 2003
Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations
Stephen Taylor, Patricia Cane, Stéphane Hué, et al.
AIDS (London, England)
|
September 26, 2014
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study
Jonathan Z Li, Andrea Heisey, Hayat Ahmed, et al.
AIDS (London, England)
|
October 9, 2002
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates
Jeannette M Whitcomb, Wei Huang, Kay Limoli, et al.
Plos One
|
March 21, 2015
Glycans flanking the hypervariable connecting peptide between the A and B strands of the V1/V2 domain of HIV-1 gp120 confer resistance to antibodies that neutralize CRF01_AE viruses
Sara M O'Rourke, Ruengpung Sutthent, Pham Phung, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
December 13, 2023
SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk
Mazen Khalifeh, Lorry G Rubin, David Dayya, et al.
Page
of 11